Study of ENMD-2076 in Patients With Multiple Myeloma

NCT00806065 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: ENMD-2076

Sponsor

CASI pharmaceuticals, Inc.